Clincosm LogoSign in Get a demo

cnv

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AMD, nAMD, Wet Age-related Macular Degeneration Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Aflibercept (EYLEA®))

Recruiting
  • AMD
  • +5 more
  • RGX-314 Dose 1
  • +2 more
  • Encino, California
  • +16 more
Jun 2, 2022

Retinal Structure With High Resolution Optical Coherence

Recruiting
  • Macular Edema
  • CNV
  • Examination with an OCT device
  • Bern, Switzerland
  • +1 more
Oct 4, 2021

Reinterpretation of CNV With Unknown Significance:5-year

Completed
  • Genetic Disease
  • +3 more
  • reinterpretation of CNV
  • Nancy, France
    Lorraine University
Sep 29, 2020

Combretastatin A4 Phosphate, Age-related Macular Degeneration, AMD Trial in Baltimore (Combretastatin A-4 phosphate,

Completed
  • Combretastatin A4 Phosphate
  • +4 more
  • Combretastatin A-4 phosphate
  • Combretastatin A-4 Phosphate
  • Baltimore, Maryland
    Wilmer Eye Institute
Dec 4, 2017

Age Related Macular Degeneration, AMD, CNV Trial in New York (Efalizumab, Ranibizumab)

Withdrawn
  • Age Related Macular Degeneration
  • +2 more
  • Efalizumab, Ranibizumab
  • New York, New York
    Vitreous Retina Macula Consultants of New York
Jul 6, 2015